Analysis of growth characteristics of filamentous fungi in different nutrient media

Journal of Clinical Microbiology

Volumn 39, Issue 2, 2001, Pages 478-484

  Meletiadis, J ^a   Meis, J F G M ^a   Mouton, J W ^a   Verweij, P E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CULTURE MEDIUM; FUNGUS GROWTH; FUNGUS SPORE; GROWTH CURVE; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS; SCEDOSPORIUM; TURBIDITY;

ASPERGILLUS FUMIGATUS; CULTURE MEDIA; KINETICS; RHIZOPUS; SCEDOSPORIUM; TIME FACTORS;

ASPERGILLUS FUMIGATUS; FUNGI; MICROSPORUS; RHIZOPUS MICROSPORUS; SCEDOSPORIUM PROLIFICANS;

EID: 0035130349     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.2.478-484.2001     Document Type: Article

References (37)

1. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans
2. Standardization of antifungal susceptibility testing
3. Standardization of antifungal susceptibility testing and clinical relevance
4. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
5. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
6. Factors affecting the changes in amphotericin B sensitivity of Candida albicans during growth
7. Antimicrobial susceptibility testing of yeasts: A turbidimetric technique independent of inoculum size
8. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method
9. Susceptibility testing of fungi and correlation with clinical outcome
10. Susceptibility testing of Cryptococcus neoformans: A microdilution technique
11. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance
12. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi
13. Obfuscation of the activity of antifungal antimicrobics by culture media
14. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester
15. Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole
16. Factors influencing the susceptibility of Candida albicans to the polyenic antibiotics nystatin and amphotericin B
17. Microbiology and plant protoplasts
18. Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods
19. Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids
20. Determining the effects of antibiotics on bacterial growth tby optical and electrical methods
21. Effects of pH on the activity of ketoconazole against Candida albicans
22. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi
23. The new fungal opportunists are coming
24. Collaborative investigation of variables in susceptibility testing of yeasts
25. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments
26. Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B against Fusarium
27. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome
28. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method
29. Antifungal susceptibility testing
30. Opportunistic and pathogenic fungi
31. Defining conditions for microbroth antifungal susceptibility tests: Influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria
32. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: A comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose
33. Current and emerging azole antifungal agents
34. Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans
35. The action of miconazole on the growth of Candida albicans
36. Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management